{
    "code": "02007630",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02007630",
    "time": "2020-02-25 09:03:24",
    "許可證字號": "衛署藥輸字第007630號",
    "註銷狀態": "已註銷",
    "註銷日期": "76\/10\/12",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "95\/08\/31",
    "發證日期": "69\/09\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200763009",
    "中文品名": "淤老改那血注射劑６，０００國際單位",
    "英文品名": "UROKINASE INJECTION 6000 I.U. &quot;WAKAMOTO&quot;",
    "適應症": "動、靜脈血栓症、冠動脈閉塞症、腦血管閉塞症、心肌梗塞症",
    "劑型": "270注射劑",
    "包裝": "小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "UROKINASE, DEXTRAN 40",
    "限制項目": "02輸　入",
    "申請商名稱": "1411401100  臺灣藤澤藥品工業股份有限公司",
    "申請商地址": "台北巿敦化南路一段３２５號三樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0393000  WAKAMOTO PHARMACEUTICAL CO. LTD.",
            "製造廠廠址": "5-3, NIHONBASHI MUROMACHI 1-CHOME,CHUO-KU,TOKYO 103-8330    JAPAN5-3,NIHONBASHI, MUROMACHI 1-CHOME, CHUO-KU TOKYO, JAPAN.",
            "製造廠公司地址": "5-3,NIHONBASHI, MUROMACHI 1-CHOME, CHUO-KU TOKYO, JAPAN.",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2040000200",
            "成分名稱": "UROKINASE",
            "含量描述": "6000",
            "含量": "6000.0000000000",
            "單位": "IU (I"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4012000700",
            "成分名稱": "DEXTRAN 40",
            "含量描述": "10",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ]
}